Crossmark

Liquid foam improves potency and safety of gene therapy vectors

Crossref DOI link: https://doi.org/10.1038/s41467-024-48753-9

Published Online: 2024-05-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fitzgerald, K. https://orcid.org/0009-0007-5544-8397
Stephan, S. B. https://orcid.org/0009-0008-3800-3748
Ma, N.

Wu, Q. V. https://orcid.org/0000-0002-2292-4816
Stephan, M. T. https://orcid.org/0000-0001-8310-0100
License Information

Text and Data Mining valid from 2024-05-28

Version of Record valid from 2024-05-28
More Information

Article History

Received: 29 November 2023

Accepted: 13 May 2024

First Online: 28 May 2024

Competing interests

: The authors declare no competing interests.